Molecular therapy for Stroke: Fluoxetine, an anti-depressant drug, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 18/September/2017, 10.57 pm
https://genomediscovery.org/wp-content/uploads/2017/09/Fluoxitine-induces-BDNF-and-NAMPT-expression-and-attenuates-stroke.jpg
960
720
Dr Boomi's Genom-2-Discovery Center
https://genomediscovery.org/wp-content/uploads/2017/09/Fluoxitine-induces-BDNF-and-NAMPT-expression-and-attenuates-stroke.jpg
Introduction: What they say A recent study from Research Center for Neurobiology and Department of Neurobiology, Xuzhou Medical College, 209 Tongshan Road, Xuzhou, Jiangsu 221004, PR China; and School of Public…
read more

